UTokyo's Innovation Platform joined subsidiaries of SBI, Sumitomo Mitsui and Mizuho Bank to help double genetic disorder treatment developer EdiGene's funding.

Cancer drug developer NH Theraguix was incubated by Satt Pulsalys to advance a nanoparticle-based drug for solid tumours that works by enhancing the efficacy of radiotherapy treatment and MRI scans.

The innovation challenge platform, which counts Bouygues Telecom as an investor, has received $14.5m in a round that featured the Sipa-Ouest‑France-backed Sofiouest.

HDI Global led internet-of-things and insurance incubator Next Big Thing's $13.5m series A round, participating together with Finlab EOS.

The broadband supplier plans to upgrade its network having sourced commitments from Wabash Valley Power and seven telecommunication firms.

Vector has received funding from UC-backed Congruent Ventures among others as it looks to enhance its software in supporting back office logistics functions.

NUI Maynooth spinout Avectas has added capital to converted equity previously supplied by therapeutics developer Adapt Pharma among others.

Proceeds from the series round, which was co-led by Intel Capital and National Grid Partners, will fund the development of Pixeom's edge computing software platform.

AP Moller – Maersk took part in an $11.2m round that will accelerate the international expansion of the food logistics marketplace.

The cannabis-focused vaping product maker has increased its overall funding to approximately $14.7m with a $10.4m round backed by Newstrike Brands.